Advertisement
Covidien
Subscribe to Covidien
View Sample

FREE Email Newsletter

South Korea is a "key market" in Covidien's global strategy

August 27, 2013 1:36 pm | by Mass Device | News | Comments

Massachusetts medical device maker Covidien is opening the doors on a new Center of Innovation in South Korea, a country that the company calls "a key market in our global strategy." Covidien plans to spend $21 million over the course of 3 years to support the center...

Covidien Opens US$21 Million Research & Development and Training & Education Center in South Korea

August 27, 2013 7:00 am | by Business Wire | News | Comments

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the opening of the Covidien Center of Innovation Korea (CCI Korea), its first research & development (R&D) and training & education center in Korea. With a total investment of US$21 million over a three year period, CCI Korea is a high-tech medical training center focused on raising awareness of various disease states...

Covidien recalls flush syringes

August 20, 2013 1:59 pm | by Mass Device | News | Comments

Covidien recalled some lots of its Monoject syringes after discovering a sterilization mishap and labeling problem. The issues affected 14 lots in shipments that went out to customers in the U.S. and Bermuda, the Mansfield, Mass.-based medical products giant said.

Advertisement

CAS Medical wins a legal round against Covidien's Nellcor

August 12, 2013 11:31 am | by Mass Device | News | Comments

CAS Medical (NSDQ:CASM) won a round in a legal battle with Covidien's (NYSE:COV) Nellcor patient monitoring subsidiary over technology used to measure oxygen levels in the brain, after a federal judge in Michigan tossed a breach-of-contract claim against CasMed.

Covidien launches 2 trials to support its Stellarex drug-device combo

July 17, 2013 9:58 am | by Mass Device | News | Comments

Covidien kicked off 2 new clinical trials this week to support a global evaluation of its Stellarex drug-coated angioplasty balloon. The Massachusetts-based company started enrolling patients with peripheral arterial disease in the Pivotal and PK arms of its larger ILLUMENATE clinical trials examining the safety and effectiveness of Covidien's Stellarex devices.

Covidien and Nuvon Release New Interface Supporting Electronic Charting

July 9, 2013 2:00 pm | by Covidien | News | Comments

Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, has released a new interface making the INVOS™ cerebral oximetry system compatible with the Nuvon System. The technology allows hospitals to integrate patient data with Electronic Medical Record (EMR) systems.

U.S. Disallows $2.86B in Deductions Taken by Tyco

July 8, 2013 4:23 pm | by The Associated Press | News | Comments

The U.S. tax agency has informed Tyco International Ltd. that it has disallowed roughly $2.86 billion in interest and deductions recognized by the company in its tax returns for the 1997-2000 tax years, according to a filing with the Securities and Exchange Commission.

Covidien could be on the hook for nearly $450M in back taxes

July 2, 2013 12:23 pm | by Mass Device | News | Comments

Covidien could wind up stuck with its share of a $1.07 billion tax bill, after the IRS told its former corporate parent, Tyco International, that tax deductions it took from 1997 to 2000 will be disallowed, according to a regulatory filing.  

Advertisement

Covidien Completes Separation of Pharmaceuticals Business

July 1, 2013 7:00 am | by Business Wire | News | Comments

Covidien, a leading global provider of healthcare products, today announced it has completed the separation of its Pharmaceuticals business, which is now held by Mallinckrodt plc, a new independent company. Mallinckrodt will begin “regular way” trading on the New York Stock Exchange today under the symbol "MNK."

Covidien Announces Publication of Final Results of Pipeline Embolization Device Pivotal Study

June 21, 2013 7:00 am | by Business Wire | News | Comments

Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of its Pipeline™ embolization device have been published in the June issue of Radiology. Radiology is the official peer-reviewed medical journal of the Radiological Society of North America.

CLOTS 3 Study Delivers Lifesaving Results Using Covidien’s Blood Clot Prevention Technology

June 20, 2013 3:00 am | by Business Wire | News | Comments

Covidien (NYSE: COV), a leading global provider of healthcare products, has announced that an independent study conducted by the University of Edinburgh has successfully demonstrated the effectiveness of Covidien’s Kendall SCD™ system with Vascular Refill Detection Technology on immobile stroke patients.

Accessible CO2 Technology Increases Caregiver Efficiency

June 13, 2013 3:09 pm | by Linda Broido, Global Product Manager, Covidien | Blogs | Comments

In today’s medical facilities, healthcare providers face heavy workloads and care for more patients with decreased clinical staff. They need products and technologies that help them provide effective care as efficiently as possible. At Covidien, our goal is to provide monitoring solutions that enhance patient care in a range of clinical environments.

Next-Generation Clot Retrieval Technology Improves Patient Outcomes vs. First- Generation Devices, Say Leading Stroke Physicians

June 11, 2013 11:59 am | by Covidien | News | Comments

Covidien brought together six of the world’s prominent thought-leaders in stroke at the 2013 European Stroke Conference. At a Covidien-sponsored symposium, the stroke experts presented and discussed data underscoring the benefits of endovascular therapy in treating acute ischemic stroke and, particularly, the important role that new devices play when this procedure is performed to remove blood clots from large vessels in the brain.

Advertisement

Medical Device Technology: Our Best Hope for Delivering Global Healthcare

May 29, 2013 11:36 am | by Simon Karger, Associate Director, Surgical & Interventional, Cambridge Consultants | Cambridge Consultants Inc | Blogs | Comments

The technology at the heart of the next generation of medical devices is critical to our ability to offer comprehensive care in the coming decades. While our current systems of care have served us well thus far, they are crumbling under the pressures of modern expectations of care, economics, scale, and the sheer breadth of medical science.

Covidien Nellcor Pulse Oximeters Receive FDA 510(k) Clearance with Labeling for Use in Newborn Screening for Critical Congenital Heart Disease

May 28, 2013 12:35 pm | by Covidien | News | Comments

Covidien’s new CCHD labeling was introduced as part of the FDA 510(k)-cleared labeling for motion tolerant Nellcor pulse oximeters. In 2011, the U.S. Department of Health and Human Services added CCHD screening to the Federal Recommended Uniform Screening Panel Guidelines.

Covidien’s Technology Platform to Diagnose Early Lung Cancer Part of New Guidelines of American College of Chest Physicians

May 21, 2013 6:59 am | by The Associated Press | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--May 21, 2013--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that its superDimension Electromagnetic Navigation Bronchoscopy (ENB™) system, the first technology of its kind, is included in the new American College of Chest...

Covidien Receives FDA 510(k) Clearance for Nellcor Pulse Oximetry Motion Claims

May 20, 2013 11:11 am | by Covidien | News | Comments

Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced that its Nellcor™ pulse oximetry portfolio, which is used to measure arterial oxygen saturation, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for motion claims.

Medical Device Global Labeling Strategies Conference

May 9, 2013 2:07 pm | by MDT Staff | Events

Gain best practices in overcoming international labeling challenges at the Medical Device Global Labeling Strategies Conference, July 24-25, 2013 in Minneapolis, MN. This premier marcus evans event will bring together leading medical device labeling professionals to discuss how to successfully create a label on both a national and international scale.

Covidien Unveils Innovative Capnography Solution for OEM Partners

May 9, 2013 10:16 am | by Covidien | News | Comments

Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, has launched the Microstream® MicroPod™ module. This is an important product for its Original Equipment Manufacturer (OEM) partners that will help hospitals improve patient safety by expanding access to capnography technology.

Recall: Covidien pulls ventilator batteries amid defect concerns

April 19, 2013 3:54 pm | by Mass Device | News | Comments

Massachusetts-based medical device maker Covidien announced a voluntary recall of certain Power Pac batteries distributed with its Newport HT70 and HT70 Plus ventilators, according to an FDA notice. Covidien launched the recall in response to reports that some batteries were resorting to back-up power sooner than expected while operating on the Power Pac battery.

Covidien Awarded $176.5M in Patent Lawsuit

March 29, 2013 2:36 pm | by The Associated Press | News | Comments

Irish drug and medical device maker Covidien said Friday that a federal court in Connecticut has awarded it $176.5 million after ruling that a Johnson & Johnson unit infringed on three of its ultrasonic surgical products patents. The lawsuit against J&J's Ethicon Endo-Surgery Inc. was...

Covidien Awarded $176.5 Million Verdict in Patent Litigation against Ethicon Endo-Surgery

March 29, 2013 12:54 pm | by The Associated Press | News | Comments

NEW HAVEN, Conn.--(BUSINESS WIRE)--Mar 29, 2013--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has won a patent infringement suit against Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, relating to Ethicon's Harmonic® line of...

Covidien Closes Enrollment in Iliac Stent Studies

February 21, 2013 11:38 am | by Mass Device | News | Comments

Covidien said it closed enrollment in a pair of its Visibility and Durability iliac stent clinical studies. The prospective, multinational studies are designed to compare balloon stents with self-expanding stents in the iliac arteries for treating peripheral artery disease.

Two-Year Clinical Study Supports Safety and Efficacy of Covidien Revascularization Device

February 7, 2013 6:42 pm | by The Associated Press | News | Comments

MANSFIELD, Mass.--(BUSINESS WIRE)--Feb 7, 2013--Covidien (NYSE:COV), a leading global provider of healthcare products, today released the results of the Solitaire™ FR Thrombectomy for Acute Revascularization (STAR) study. The two-year study evaluated the safety and efficacy of the Solitaire FR...

Covidien Supports Centers for Medicare & Medicaid Services Quality Measure #3040

January 21, 2013 9:24 am | by Covidien | News | Comments

Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announces its support for the Centers of Medicare & Medicaid Services (CMS) proposed quality measure #3040, currently considered for a Medicare program rule. Quality measures help CMS assess performance of hospitals participating...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading